Sab Biotherapeutics Stock Analysis
| SABSW Stock | USD 0.07 0.0005 0.73% |
SAB Biotherapeutics is overvalued with Real Value of 0.0465 and Hype Value of 0.07. The main objective of SAB Biotherapeutics stock analysis is to determine its intrinsic value, which is an estimate of what SAB Biotherapeutics is worth, separate from its market price. There are two main types of SAB Biotherapeutics' stock analysis: fundamental analysis and technical analysis.
The SAB Biotherapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. SAB Biotherapeutics is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. SAB Stock trading window is adjusted to America/New York timezone.
SAB |
SAB Stock Analysis Notes
The company had not issued any dividends in recent years. To find out more about SAB Biotherapeutics contact the company at 605 679 6980 or learn more at https://www.sabbiotherapeutics.com.SAB Biotherapeutics Investment Alerts
| SAB Biotherapeutics is way too risky over 90 days horizon | |
| SAB Biotherapeutics has some characteristics of a very speculative penny stock | |
| SAB Biotherapeutics appears to be risky and price may revert if volatility continues | |
| SAB Biotherapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.24 M. Net Loss for the year was (42.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| SAB Biotherapeutics generates negative cash flow from operations | |
| Latest headline from news.google.com: SAB Bios Q3 Loss Widens to 10.3M Despite Progress in Diabetes Drug Trial SABS Stock News - StockTitan |
SAB Biotherapeutics Thematic Classifications
In addition to having SAB Biotherapeutics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
SAB Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.50) | (0.53) | |
| Return On Capital Employed | (0.52) | (0.55) | |
| Return On Assets | (0.50) | (0.53) | |
| Return On Equity | (0.74) | (0.70) |
Management Efficiency
The company has return on total asset (ROA) of (0.788) % which means that it has lost $0.788 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7473) %, meaning that it generated substantial loss on money invested by shareholders. SAB Biotherapeutics' management efficiency ratios could be used to measure how well SAB Biotherapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.53 in 2024. Return On Capital Employed is likely to drop to -0.55 in 2024. At this time, SAB Biotherapeutics' Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to climb to about 2.7 M in 2024, whereas Total Assets are likely to drop slightly above 63.5 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 10.38 | 7.50 | |
| Tangible Book Value Per Share | 10.38 | 7.50 | |
| Enterprise Value Over EBITDA | 0.33 | 0.35 | |
| Price Book Value Ratio | 0.66 | 0.70 | |
| Enterprise Value Multiple | 0.33 | 0.35 | |
| Price Fair Value | 0.66 | 0.70 | |
| Enterprise Value | -12.7 M | -12 M |
Leadership at SAB Biotherapeutics emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Operating Margin (34.23) | Beta 0.641 | Return On Assets (0.79) | Return On Equity (1.75) |
Technical Drivers
As of the 29th of November, SAB Biotherapeutics owns the Market Risk Adjusted Performance of (7.32), standard deviation of 20.3, and Semi Deviation of 11.04. In respect to fundamental indicators, the technical analysis model makes it possible for you to check possible technical drivers of SAB Biotherapeutics, as well as the relationship between them. Please validate SAB Biotherapeutics mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if SAB Biotherapeutics is priced fairly, providing market reflects its prevailing price of 0.0683 per share. As SAB Biotherapeutics appears to be a penny stock we also recommend to double-check its total risk alpha numbers.SAB Biotherapeutics Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. SAB Biotherapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for SAB Biotherapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
SAB Biotherapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SAB Biotherapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on SAB Biotherapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SAB Biotherapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ellias Helen K. over a month ago Discretionary transaction by Ellias Helen K. of 2857142 shares of SAB Biotherapeutics at 0.63 subject to Rule 16b-3 | ||
Moin Andrew over three months ago Discretionary transaction by Moin Andrew of 2747097 shares of SAB Biotherapeutics at 0.63 subject to Rule 16b-3 |
SAB Biotherapeutics Predictive Daily Indicators
SAB Biotherapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SAB Biotherapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0683 | |||
| Day Typical Price | 0.0683 | |||
| Price Action Indicator | (0.0003) | |||
| Period Momentum Indicator | (0.0005) | |||
| Relative Strength Index | 54.73 |
SAB Biotherapeutics Forecast Models
SAB Biotherapeutics' time-series forecasting models are one of many SAB Biotherapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SAB Biotherapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About SAB Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how SAB Biotherapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SAB shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SAB Biotherapeutics. By using and applying SAB Stock analysis, traders can create a robust methodology for identifying SAB entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (18.85) | (17.90) | |
| Operating Profit Margin | (17.01) | (16.16) | |
| Net Loss | (18.85) | (17.90) | |
| Gross Profit Margin | (0.67) | (0.64) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SAB Biotherapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Additional Tools for SAB Stock Analysis
When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.